Haemonetics Anticoagulant Sodium Citrate (Haemonetics Corporation)


Welcome to the PulseAid listing for the Haemonetics Anticoagulant Sodium Citrate drug offered from Haemonetics Corporation. This Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: Haemonetics Corporation
NON-PROPRIETARY NAME: TRISODIUM CITRATE DIHYDRATE
SUBSTANCE NAME: TRISODIUM CITRATE DIHYDRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA]
ROUTE: EXTRACORPOREAL
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2013-01-10
END MARKETING DATE: 0000-00-00


Haemonetics Anticoagulant Sodium Citrate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionHaemonetics Anticoagulant Sodium Citrate from Haemonetics Corporation
LABELER NAME: Haemonetics Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 40(mg/mL)
START MARKETING DATE: 2013-01-10
END MARKETING DATE: 0000-00-00
PRODUCT ID: 57826-420_5c644a2c-2dc3-c305-e053-2991aa0a97fe
PRODUCT NDC: 57826-420
APPLICATION NUMBER: BN980123

Other TRISODIUM CITRATE DIHYDRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alva-Amco Pharmacal Companies, Inc.Nauzene
Citra Labs LLCtriCitrasol
Fenwal, Inc.Sodium Citrate Blood-Pack Units, (PL 146 Plastic)
Fresenius Kabi USA, LLCSodium Citrate Blood-Pack Units, (PL 146 Plastic)
Haemonetics CorporationHaemonetics Anticoagulant Sodium Citrate